Shogo Kobayashi
Overview
Explore the profile of Shogo Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
419
Citations
3813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomimaru Y, Kobayashi S, Sasaki K, Hasegawa S, Yamada D, Akita H, et al.
Surg Endosc
. 2025 Mar;
PMID: 40038118
Background: Hypoattenuated area (HA) formation at the pancreatojejunostomy (PJ) site on contrast-enhanced computed tomography (CE-CT) is significantly associated with clinically relevant postoperative pancreatic fistula (CR-POPF) after open pancreaticoduodenectomy (PD) (O-PD)....
2.
Imamura H, Tomimaru Y, Kobayashi S, Harada A, Kita S, Sasaki K, et al.
Sci Rep
. 2025 Feb;
15(1):6334.
PMID: 39984656
We investigated the potential of adipose-derived stem cells (ADSCs) in preventing post-hepatectomy liver failure, emphasizing the necessity of direct administration using a scaffold. A fibrin gel scaffold was employed for...
3.
Maki R, Iwagami Y, Kobayashi S, Sasaki K, Yamada D, Tomimaru Y, et al.
J Hepatobiliary Pancreat Sci
. 2024 Nov;
31(12):e62-e65.
PMID: 39489710
This report by Maki and colleagues with accompanying surgical video introduces a less invasive surgical option for managing right atrial tumor thrombus in hepatocellular carcinoma, avoiding sternotomy. This approach might...
4.
Okimura S, Nishida N, Takahashi H, Yokoyama Y, Yamamoto H, Hamabe A, et al.
Anticancer Res
. 2024 Oct;
44(11):4737-4749.
PMID: 39477301
Background/aim: The membrane-bound protein lymphocyte antigen 6 family member D (LY6D), a marker of early B cell lineage is reportedly expressed in several human malignancies and has been implicated in...
5.
Ueda H, Takahashi H, Kobayashi S, Tomimaru Y, Kubo M, Sasaki K, et al.
Ann Surg Oncol
. 2024 Sep;
32(1):529-530.
PMID: 39299990
The efficacy of preoperative treatment for pancreatic cancer (PC) has been reported in randomized controlled trials, but the optimal regimen and the appropriateness of combining radiotherapy remain controversial. Therefore, predicting...
6.
MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma
Takeda Y, Yamada D, Kobayashi S, Sasaki K, Iwagami Y, Tomimaru Y, et al.
PLoS One
. 2024 Sep;
19(9):e0310328.
PMID: 39288140
Pancreatic ductal adenocarcinoma (PDAC) has a high recurrence rate even after radical resection because of subclinical tumors. To manage them, a reliable biomarker that can indicate the presence of subclinical...
7.
Ueda H, Takahashi H, Sakaniwa R, Kitamura T, Kobayashi S, Tomimaru Y, et al.
Pancreatology
. 2024 Sep;
24(7):1097-1106.
PMID: 39278808
Background/objectives: MicroRNAs (miRNAs) are involved in chemosensitivity through their biological activities in various malignancies, including pancreatic cancer (PC). However, single-miRNA models offer limited predictability of treatment response. We investigated whether...
8.
Ueda H, Takahashi H, Kobayashi S, Kubo M, Sasaki K, Iwagami Y, et al.
Ann Surg Oncol
. 2024 Sep;
32(2):720-735.
PMID: 39269634
Background: Whether radiation should be added to neoadjuvant treatment remains controversial, and liquid biopsy has not been reported to predict radioresistance in pancreatic cancer (PC). We aimed to identify microRNAs...
9.
Yamada D, Takeda Y, Takahashi H, Sasaki K, Iwagami Y, Tomimaru Y, et al.
Eur J Surg Oncol
. 2024 Sep;
50(12):108650.
PMID: 39244977
Background: The suitability of radical surgery for very elderly pancreatic cancer (PC) patients remains controversial due to concerns about postoperative functional reserve. Inflammatory-nutritional status may help identify elderly patients at...
10.
Shinke G, Takeda Y, Ohmura Y, Kobayashi S, Wada H, Morimoto O, et al.
Ann Gastroenterol Surg
. 2024 Sep;
8(5):868-876.
PMID: 39229564
Purpose: Postoperative venous thromboembolism (VTE) risk is pronounced after abdominal cancer surgery. Enoxaparin shows promise in preventing VTE in gastrointestinal, gynecological, and urological cancers, but its application after surgery for...